Related Experiment Video
Updated: Jun 25, 2026

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Published on: October 3, 2012
Surface charge of polyoxometalates modulates polymerization of the scrapie prion protein
Holger Wille1, Maheswaran Shanmugam, Muralee Murugesu
1Institute for Neurodegenerative Diseases and Department of Neurology, University of California, San Francisco, CA 94143, USA. hwille@ind.ucsf.edu
Abstract:
Prions are composed solely of an alternatively folded isoform of the prion protein (PrP), designated PrP(Sc). N-terminally truncated PrP(Sc), denoted PrP 27-30, retains infectivity and polymerizes into rods with the ultrastructural and tinctorial properties of amyloid. We report here that some polyoxometalates (POMs) favor polymerization of PrP 27-30 into prion rods, whereas other POMs promote assembly of the protein into 2D crystals. Antibodies reacting with epitopes in denatured PrP 27-30 also bound to 2D crystals treated with 3 M urea. These same antibodies did not bind to either native PrP(Sc) or untreated 2D crystals. By using small, spherical POMs with Keggin-type structures, the central heteroatom was found to determine whether prion rods or 2D crystals were preferentially formed. An example of a Keggin-type POM with a phosphorous heteroatom is the phosphotungstate anion (PTA). Both PTA and a Keggin-type POM with a silicon heteratom have low-charge densities and favor formation of prion rods. In contrast, POMs with boron or hydrogen heteroatoms exhibiting higher negative charges encouraged 2D crystal formation. The 2D crystals of PrP 27-30 produced by selective precipitation with POMs were larger and more well ordered than those obtained by sucrose gradient centrifugation. Our findings argue that the negative charge of Keggin-type POMs determines the quaternary structure adopted by PrP 27-30. The mechanism by which POMs function in competing prion polymerization pathways--one favoring 2D crystals and the other, amyloid fibrils--remains to be established.
Insights
Polyoxometalates (POMs) influence prion protein (PrP 27-30) polymerization. Keggin-type POMs with specific heteroatoms and negative charges dictate whether prion rods or 2D crystals form, impacting prion structure.
Area of Science:
- Biochemistry
- Structural Biology
- Materials Science
Background:
- Prions are infectious agents composed of misfolded prion proteins (PrPSc).
- N-terminally truncated PrPSc (PrP 27-30) forms amyloid rods and retains infectivity.
- Understanding PrP polymerization is crucial for prion disease research.
Purpose of the Study:
- To investigate the role of polyoxometalates (POMs) in directing PrP 27-30 polymerization.
- To determine how POM structure, specifically Keggin-type POMs, influences the formation of prion rods versus 2D crystals.
- To explore the potential of POMs for creating ordered PrP structures for study.
Main Methods:
- Utilized various Keggin-type polyoxometalates (POMs) to induce polymerization of PrP 27-30.
- Analyzed the resulting structures (prion rods vs. 2D crystals) using electron microscopy and antibody binding assays.
- Varied the central heteroatom and charge density of POMs to observe effects on PrP assembly.
Main Results:
- Specific Keggin-type POMs promoted the formation of either prion rods or 2D crystals of PrP 27-30.
- POMs with low-charge densities (e.g., phosphotungstate) favored prion rod formation.
- POMs with higher negative charges (e.g., boron or hydrogen heteroatoms) promoted the assembly of well-ordered 2D crystals.
- Antibody binding indicated conformational changes in PrP 27-30 upon 2D crystal formation, especially after urea treatment.
Conclusions:
- The negative charge of Keggin-type POMs is a key determinant of PrP 27-30 quaternary structure.
- POMs offer a method for selectively producing ordered 2D PrP crystals, superior to existing techniques.
- Further research is needed to elucidate the precise mechanisms by which POMs modulate prion polymerization pathways.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Complexation Equilibria: The Chelate Effect

